Valye reports for unlimited access

AParadise Acquisition Corp. is a special purpose acquisition company (SPAC) incorporated in the British Virgin Islands in 2022. Its primary purpose is to effect a business combination with one or more target companies. The company completed its IPO in July 2025, raising $200 million, and has engaged in private placements. In November 2025, it entered into a business combination agreement with Enhanced Ltd, a Cayman Islands exempted company, to merge and domesticate to Texas, renaming as Enhanced Group Inc. The business combination involves complex share exchanges and voting arrangements. The company’s business plan post-combination includes organizing sporting events, media content, athlete compensation, medical profiling, telehealth, merchandising, and direct-to-customer products. The company has a limited operating history and has incurred significant losses. It reported revenue of $17.7 million and a net loss of $61.9 million for the six months ended June 30, 2026. The company’s liquidity as of June 30, 2026, includes $19.6 million in cash and a very high current ratio, but management has expressed substantial doubt about its ability to continue as a going concern without additional capital. The company is pursuing further private placements and may raise capital through equity or debt offerings, which could dilute shareholders or impose restrictions. Material weaknesses in internal controls have been identified and remediation efforts are underway.

Cyber Enviro-Tech, Inc. (CETI) is an environmental technology company founded in 1986, focused on sustainable remediation solutions for contaminated industrial wastewater, initially targeting the oil and gas sector. The company develops proprietary equipment, biochemical products, and treatment processes that incorporate cyber, aerospace, satellite, industrial, and AI telemetry technologies. CETI's water filtration and alternative energy systems feature neural sensors and cellular connectivity. The company previously operated an oil field pilot project in Texas, which was spun off in 2025 to focus on remediation technologies. CETI has a manufacturing and distribution agreement with Air Power USA to commercialize zero-emission compressed air energy systems for off-grid applications. Headquartered in Scottsdale, Arizona, with offices in Istanbul and Dubai, CETI operates with consultants rather than employees. Its sales strategy involves partnerships with experienced industry professionals to accelerate market penetration. The company faces regulatory compliance requirements and economic factors impacting the oil industry. CETI has reported no revenue and ongoing net losses, with liquidity constraints and reliance on financing activities to fund operations.

DISCIPLINED GROWTH ACQUISITION Corp operates as a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands. The company completed its initial public offering in May 2026, issuing units consisting of Class A ordinary shares and rights to additional shares upon a business combination. The company’s primary objective is to identify and consummate an initial business combination within a specified timeframe. It holds IPO proceeds in a trust account to fund the business combination. The company is listed on the New York Stock Exchange under the symbols DGAC (Class A shares), DGACU (units), and DGACR (rights).

D. Boral Acquisition I Corp. is a Special Purpose Acquisition Company (SPAC) incorporated in the British Virgin Islands. Its business model is to raise capital through an IPO and private placement to acquire one or more businesses through a merger or similar transaction. The company completed its IPO in February 2026, raising $287.5 million, which is held in a trust account invested in U.S. government treasury obligations or money market funds. The company’s management team has significant experience in SPAC transactions and investment banking, having led or advised on over 70 SPAC deals totaling over $8 billion. The company intends to leverage its management’s expertise and network to identify and acquire a target business that aligns with its strategic criteria, including companies with attractive competitive positions, experienced management, growth potential, and scalability. The company has a limited timeframe (18 months plus possible extensions) to complete its initial business combination or face liquidation and redemption of public shares. The company is not currently operating any business and will rely on the proceeds from the IPO and other financing arrangements to complete its acquisition.

SIM Acquisition Corp. I is a blank check company formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company has no operating history or revenues and is currently focused on completing its initial business combination. On April 26, 2026, SIM Acquisition Corp. I entered into a non-binding Letter of Intent to acquire American Industrial Technologies, Inc. (AIT), a company with a 33-year history in telecommunications and logistics, serving Tier 1 and Tier 2 carriers across multiple regions including the United States, Europe, and Latin America. The company is subject to typical SPAC risks including the possibility of not completing a business combination within the required timeframe, dilution risks, and regulatory and market uncertainties.

Oxley Bridge Acquisition Ltd is a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands in August 2024. Its business model is to identify and complete a Business Combination with one or more target companies primarily in the global consumer and technology sectors, focusing on opportunities in Asia excluding China. The company completed its IPO in June 2025, raising $253 million, which is held in a Trust Account to fund the Business Combination. The company has not generated operating revenues and is currently in the search and evaluation phase for suitable acquisition targets. The management team brings extensive experience in investment, operations, and public markets, aiming to leverage their network and expertise to identify companies with strong fundamentals, market leadership, and public market readiness. The company targets acquisition candidates with enterprise values generally between $500 million and $1 billion. The company faces competition from other SPACs and investors for attractive targets and must complete its Business Combination by June 26, 2027, or liquidate and return funds to shareholders.

Scientific Industries, Inc. is a manufacturer and marketer of benchtop laboratory equipment and bioprocessing systems. The company’s Benchtop Laboratory Equipment segment includes weighing instruments, automated pill counters, and moisture analyzers marketed under the Torbal® and VIVID® brands. The Bioprocessing Systems segment, operated through subsidiaries including aquila biolabs GmbH, develops products incorporating smart sensors and software analytics for laboratory-scale bioprocess monitoring and control. The company designs and develops most products in-house and sells primarily to research institutions, pharmaceutical companies, and related industries. It operates facilities in New York and Germany and markets products through direct sales forces and distributors. The company sold its Genie product line in 2025 but continues to focus on the remaining Benchtop products and bioprocessing development [S1][S2].

American Picture House Corporation operates in the entertainment sector, specializing in the development, packaging, financing, and production of feature films and limited series. The company shifted focus in 2025 to internally developed projects and strategic partnerships, aiming to apply disciplined underwriting and structured deal terms to the independent film market. APHP participates in various stages of filmmaking, emphasizing development, packaging, and financing, and seeks to build an owned or controlled intellectual property library. The company holds interests in several films released or in production between 2025 and 2026. Capital management focuses on flexibility and dilution awareness, with financing through cash flows, equity issuances, and other arrangements. The CEO and Chairperson holds majority voting control through common and preferred shares.

Lifeloc Technologies, Inc specializes in breath alcohol testing devices utilizing fuel cell technology, a mature technology developed over many years. The company operates in a competitive industry with larger competitors possessing greater resources. It relies on a limited number of customers and global third-party suppliers, exposing it to risks from economic, geopolitical, and natural events. The company manages cybersecurity risks through third-party providers and maintains oversight via its Audit Committee. Financially, Lifeloc reported revenues of $2.44 million and a net loss of $134,330 for the quarter ended June 30, 2026, with a strong current ratio of 4.35 and cash ratio of 2.05. The principal stockholder owns a controlling interest, influencing corporate governance and strategic decisions. The company has outstanding debt obligations with balloon payments due in 2030 and 2031. Lifeloc has not paid dividends and intends to retain earnings to support operations and expansion [S1][S2].

Texas Ventures Acquisition III Corp is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in July 2024. It has no operations of its own and was formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company completed its IPO in April 2025, raising $225 million, and its units began trading on Nasdaq. The proceeds from the IPO and private placement of warrants are held in a trust account invested in U.S. government securities until a business combination is completed or funds are returned to shareholders. The company’s management team has broad discretion over the use of proceeds, primarily to consummate a business combination. As of mid-2026, the company is engaged in discussions with a potential target but has not finalized any agreements.

ACRO BIOMEDICAL CO., LTD. operates in the nutritional products sector, specializing in cordyceps-based products used in traditional Chinese medicine. The company purchases products from suppliers in Taiwan and sells primarily to distributors who may use these products as ingredients. The business plan is in early stages, with no recent revenue or inventory purchases since mid-2022. The company faces significant challenges including limited funding, minimal operational activity, and regulatory compliance requirements in various jurisdictions. It has no patents or intellectual property and competes with better-established companies in the cordyceps market.

Nektar Therapeutics develops immunomodulatory therapies targeting autoimmune and oncology indications. Its lead candidate, rezpegaldesleukin, is in Phase 3 clinical trials for moderate-to-severe atopic dermatitis and planned Phase 3 trials for alopecia areata. The company also advances NKTR-255 and NKTR-0165 in clinical and preclinical stages. Nektar relies on collaborations and capital markets to fund development, having completed multiple equity offerings recently. The company sold its manufacturing facility in 2024 and holds a significant equity stake in Gannet BioChem. Financially, Nektar reported a net loss in Q2 2026 but maintains strong liquidity ratios. The business model centers on advancing clinical programs, securing regulatory approvals, and partnering for commercialization. Risks include clinical trial uncertainties, competitive pressures, and reliance on partners for development and sales [S1][S2].

NextPlat Corp operates in e-Commerce and healthcare sectors, focusing on expanding operations, developing new platforms and services, and pursuing acquisitions. The company has experienced significant net losses and accumulated deficits, reflecting ongoing investments and operational challenges. It reported revenues of approximately $5.87 million in 2019 and continues to manage cash flows and liquidity with a current ratio of 2.29 as of mid-2026. The company has taken corporate actions, including a reverse stock split, to maintain Nasdaq listing compliance.

Range Capital Acquisition Corp II is a Cayman Islands-incorporated blank check company established in May 2025. Its primary purpose is to effectuate a business combination through merger, acquisition, or similar transactions. The company completed its IPO in October 2025, issuing units consisting of Class A ordinary shares and redeemable warrants, raising gross proceeds of approximately $236.6 million including private placements. The proceeds are held in a Trust Account to be used for the business combination. The company has not commenced operations or generated revenues, focusing on identifying and evaluating target businesses. It incurs expenses related to public company compliance and organizational activities. The company’s governance includes experienced directors and officers with backgrounds in investment management and SPACs. Financial disclosures indicate no long-term debt and strong liquidity metrics as of mid-2026.

McKinley Acquisition Corp is a newly formed special purpose acquisition company (SPAC) incorporated in the Cayman Islands in March 2025. Its business model centers on identifying and completing a business combination with one or more operating companies, primarily targeting firms with enterprise values between $500 million and $2 billion. The company focuses on progressive, innovation-driven industries including fintech, transporttech, agtech, cleantech, spacetech, and advanced AI. The management team brings decades of experience in capital markets, M&A, and operational leadership. McKinley completed its IPO in August 2025, raising $150 million. As of mid-2026, it maintains a strong liquidity position and has entered into a definitive business combination agreement with Space-Eyes, Inc., a company specializing in AI-driven counter drone technology and geospatial intelligence. The company also actively engages with capital markets participants through events such as SPAC bootcamps.

BurTech Acquisition Corp II is a Cayman Islands exempted company that completed its initial public offering in May 2026, raising approximately $80 million through the issuance of units consisting of Class A ordinary shares and redeemable warrants. The company operates as a special purpose acquisition company (SPAC) with the objective of effecting a business combination. It has announced stockholder approval and is progressing with a merger with Blaize. The company maintains liquidity with a current ratio of 2.51 as of June 30, 2026, and holds net proceeds in a trust account for public shareholders.

CaliberCos Inc. has developed over 16 years into a leading alternative asset manager with a focus on middle-market real estate and digital assets. The firm manages private real estate investment funds and pursues a digital asset treasury strategy centered on blockchain infrastructure, primarily Chainlink tokens. Its real estate investments concentrate on multifamily, single-family, commercial, industrial, office, retail, and hospitality assets in select U.S. markets with population and job growth. The company offers a vertically integrated platform including asset management, development, brokerage, and fund formation services, generating revenues from management fees, development fees, financing fees, brokerage fees, and performance allocations. CaliberCos actively develops a substantial portfolio of real estate projects with capitalized costs nearing $1.8 billion. The firm is advancing blockchain integration and tokenization initiatives to modernize private real estate investment products and enhance investor access and compliance.

Inflection Point Acquisition Corp. IV, through its subsidiary Merlin Labs, Inc., is focused on developing advanced autonomous flight technology for fixed-wing aircraft. The flagship product, Merlin Pilot, integrates hardware and software to enable autonomous flight from takeoff to touchdown, aiming to improve flight efficiency and safety while addressing pilot shortages. The company targets both military and civilian sectors, with a significant contract awarded by the U.S. Air Force to integrate autonomous capabilities into the C-130J aircraft. The business model includes revenue from one-time hardware installation fees, recurring software support fees, and ancillary services such as software upgrades and data insights. The company is currently in the development stage, with no commercial operations to date, and is investing heavily in research and development and expanding its engineering team. Merlin Labs faces operational risks related to dependence on proprietary data from aircraft manufacturers and regulatory approvals. The company maintains strong liquidity but has reported significant net losses as it continues to develop and commercialize its technology.

zSpace, Inc. develops and sells augmented and virtual reality educational technology products, including proprietary hardware such as the Inspire laptop and software applications for STEM and Career and Technical Education. The company’s platform delivers interactive 3D learning experiences without requiring VR goggles. Revenue streams include hardware product sales, software licenses and subscriptions, and professional development services. The company’s business is sensitive to education budget cycles and government funding, which have recently caused extended sales cycles and revenue declines. zSpace partners with major PC OEMs for hardware manufacturing and relies on third-party suppliers for components. The company monitors bookings growth, annualized contract value, and customer retention metrics to assess performance. Its common stock was listed on Nasdaq in late 2024 but was delisted in 2026 due to low share price.

York Space Systems Inc. is a leading U.S.-based space and defense prime contractor focused on delivering mission-critical spacecraft and integrated solutions for national security, government, and commercial customers. The company provides a vertically integrated technology stack encompassing spacecraft design, production, integration, and operation, with turnkey offerings to manage spacecraft and constellations throughout their lifecycle. York's spacecraft platforms include the S-CLASS, LX-CLASS, and M-CLASS, which share significant hardware and software commonality to reduce costs and enable scalable solutions across a broad market. Proprietary software supports autonomous mission planning and operations, managing a global network of over 45 ground antennas. York's business model captures recurring revenue from satellite-based software and services and hardware replacement cycles. The company has expanded production capabilities with a 60,000 square foot facility capable of manufacturing and testing over 1,000 satellites annually. York's customer base primarily includes U.S. government defense and intelligence agencies, with contracts focused on missile defense, counter-space capabilities, and space domain awareness. The company completed its IPO in January 2026 and has made strategic acquisitions to enhance its technology and service offerings.

Tailwind 2.0 Acquisition Corp. operates as a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in May 2025. Its business purpose is to identify and complete an initial business combination with one or more target companies primarily in the energy and compute infrastructure sectors. The company focuses on addressing structural inefficiencies in energy routing, compute optimization, and grid intelligence. It completed its initial public offering in November 2025, raising gross proceeds of $172.5 million plus a private placement of $5.45 million. The proceeds are held in a trust account invested in U.S. government securities until a business combination is consummated or funds are returned to shareholders. The company has not yet selected a target business and has generated no revenues to date. The management team brings deep operational and capital markets expertise, with a track record of leading IPOs and building companies in relevant sectors. The company targets scalable businesses with strong leadership, clear unit economics, and defensible competitive advantages in high-growth markets related to energy intelligence, compute infrastructure, and digital optimization platforms.

Kensington Capital Acquisition Corp. VI is a Cayman Islands-based Special Purpose Acquisition Company (SPAC) listed on the New York Stock Exchange under the ticker KCAC.U. The company issues units consisting of Class A ordinary shares and redeemable warrants. As a SPAC, it holds capital in trust to complete a business combination with a target company. The company had approximately $234.6 million in total assets as of June 30, 2026, primarily held in trust. It reported a net loss of $7.62 million for the six months ended June 30, 2026, reflecting operating expenses typical for a SPAC prior to a business combination. The company maintains a strong liquidity position with a current ratio of 12.24 as of the latest quarter.

21Shares Ethereum ETF is an exchange-traded fund that issues shares representing fractional beneficial interests in a trust holding ether. The Trust's investment objective is to track the performance of ether as measured by the CME CF Ether-Dollar Reference Rate - New York Variant, adjusted for expenses and liabilities, and to reflect staking rewards if legally permissible. The Trust is a Delaware statutory trust formed in 2023 and continuously issues shares in blocks of 10,000. Shares trade on the Cboe BZX Exchange under the ticker TETH. The Trust is passive and does not actively manage or trade ether except for creation/redemption or to pay expenses. The Sponsor is 21Shares US LLC, a subsidiary of 21co Holdings Limited, ultimately owned by FalconX Holdings Limited. The Trust uses multiple Ether Custodians to hold its ether. The Sponsor pays ordinary operating expenses from a Sponsor Fee of 0.21% annualized on ether holdings, which has been waived for certain periods. The Trust calculates its net asset value daily based on the Index price and the fair value of ether in its principal market. The Trust is not registered as an investment company under the Investment Company Act of 1940 and is not regulated as a commodity pool under the Commodity Exchange Act. Shares are created and redeemed by Authorized Participants who are registered broker-dealers with agreements with the Sponsor and Administrator.

Starco Brands, Inc. operates as a holding company with subsidiaries including Starco Manufacturing, LLC and others. The company completed the acquisition of Custom Foods, LLC in July 2026, expanding its product offerings and market presence. Financing for the acquisition and working capital needs was secured through a term loan agreement with Pasadena Private Lending Inc. and a bridge loan from The Starco Group, Inc., a related party. The company reported revenues in 2024 and a net loss in the second quarter of 2026. Liquidity ratios as of June 30, 2026, indicate current liabilities exceed current assets, with a current ratio of 0.81 and a cash ratio of 0.07. The company is classified as a smaller reporting company and discloses risk factors in its annual report. No current legal proceedings were reported in the latest quarterly filing.

Aldabra 4 Liquidity Opportunity Vehicle, Inc. is a Cayman Islands exempted company established to pursue a business combination with one or more target companies. It completed its IPO in January 2026, issuing units consisting of Class A ordinary shares and redeemable warrants. The company raised approximately $300 million, which is held in a trust account until an initial business combination is completed or other specified events occur. The company targets acquisition candidates with enterprise values between $500 million and $2 billion but may consider other sizes or industries. As a SPAC, it currently has no operating revenues or business operations beyond the acquisition purpose.

Live Oak Acquisition Corp. V is a Cayman Islands exempted blank check company formed in November 2024 to pursue an initial business combination with one or more businesses. The company completed its IPO in March 2025, raising $23 million plus $4.5 million from private placement warrants. In November 2025, Live Oak entered into a merger agreement with Teamshares Inc., a tech-enabled acquiror and operator of SMEs, and completed the business combination in June 2026. Teamshares targets companies with $0.5 to $5 million EBITDA, primarily from retiring owners, across over 40 industries and 30 states in the U.S. The company uses proprietary software to source and evaluate acquisition opportunities, with purchase multiples typically ranging from 4x to 6x EBITDA. Teamshares derives revenue and cash flow from its subsidiaries, reinvesting excess cash flow into acquisitions and organic growth. The company reported $148.7 million in revenue and $20.1 million in segment EBITDA for Q2 2026, reflecting growth from acquisitions and organic initiatives. The company’s liquidity as of June 30, 2026, includes $113.4 million in cash and equivalents, with a current ratio of 0.73. The company faces refinancing risks related to near-term debt maturities and has disclosed substantial doubt about its ability to continue as a going concern.

Lantern Pharma Inc. is a biotechnology company focused on developing precision oncology therapeutics by integrating artificial intelligence and genomics. The company’s drug pipeline includes candidates such as LP-184, LP-284, LP-300, and STAR-001, targeting various cancer indications. Lantern Pharma has reported positive clinical trial results, including Phase 1a and Phase 2 studies, and has received FDA orphan drug designations. The company actively engages with regulatory authorities, including scheduled FDA meetings to discuss development plans. Financially, Lantern Pharma operates with a net loss typical of clinical-stage biotech firms but maintains liquidity through cash, short-term investments, and current assets exceeding current liabilities. The leadership team combines expertise in drug development, regulatory strategy, and financial management.

ZW Data Action Technologies Inc. is a Nevada holding company conducting its operations primarily through subsidiaries and variable interest entities (VIEs) outside mainland China. The company provides omni-channel advertising, precision marketing, influencer marketing, data analysis management, blockchain-enabled web and mobile applications, and Software-as-a-Service (SaaS) solutions. It generates revenue principally from distributing search engine marketing services, internet advertising and marketing services, intellectual property licensing, and blockchain-based SaaS services. The company has strategically shifted its focus away from search engine marketing distribution in mainland China towards higher margin digital advertising and influencer marketing services in markets outside China. It is also investing in AI capabilities and proprietary intellectual properties to improve marketing solutions and content creation. The company operates through a complex corporate structure involving subsidiaries in the British Virgin Islands, Hong Kong, and PRC operating entities controlled via contractual arrangements due to foreign investment restrictions in China. Recent acquisitions include equity interests in companies engaged in digital marketing and blockchain technology services. The company has faced Nasdaq listing compliance challenges due to its stock price falling below the required minimum bid price.

Creative Realities, Inc. is a company engaged in digital marketing technology, specializing in interactive marketing technologies and solutions. The company’s business model involves developing and marketing technology platforms and services that enable interactive advertising and media experiences. It operates in a rapidly evolving market characterized by technological innovation and competitive pressures. The company’s revenues are influenced by the timing and size of hardware and software sales, as well as SaaS service contracts, which can be variable and subject to economic and seasonal factors. The company has pursued growth through acquisitions, notably acquiring CDM, with the intent to realize operational synergies and expand its product offerings. However, the integration of acquisitions presents risks including customer retention, cost management, and operational disruption. Financially, the company has experienced net losses and negative cash flows, with liquidity ratios below 1.0 as of mid-2026, and has refinanced debt facilities to support its capital needs. The company’s ability to maintain and grow its business depends on technology development, market acceptance, competitive positioning, and access to capital.

Neumora Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company specializing in treatments for central nervous system disorders. Its development pipeline includes NMRA-215, which has shown positive toxicology results with an IND filing planned, and NMRA-511, which has reported encouraging Phase 1b data for Alzheimer's disease agitation. The company has experienced significant operational changes, including halting a Phase 3 study and workforce reductions, reflecting challenges in late-stage drug development. Financially, Neumora maintains strong liquidity with substantial cash reserves and a current ratio of 4.5 as of mid-2026, despite ongoing net losses typical of clinical-stage biotech firms.

KEEMO Fashion Group Ltd is a Nevada-incorporated company operating mainly in China, wholesaling men's and women's apparel to small and medium-sized retailers, especially home-based e-commerce businesses. The company focuses on mid-priced women's semi-formal apparel, which it believes offers higher profit margins. KEEMO operates a virtual network business model, maintaining internal functions such as procurement and sales, while outsourcing production, packaging, storage, and logistics to suppliers. Marketing efforts are in early stages, relying on the sole officer's network and planned advertising initiatives. The company faces intense competition from established wholesalers and e-commerce platforms in China. Financially, KEEMO reported no revenue and a net loss in the latest quarter, with liquidity challenges and reliance on related party financing.

LanzaTech Global, Inc. is a biotechnology company specializing in carbon capture and utilization through gas fermentation technology. Founded in 2005 and headquartered in Illinois, LanzaTech converts waste gases from industrial sources such as steel mills, refineries, and gasified waste into ethanol and other chemical products. The company’s proprietary biocatalysts ferment gases containing carbon monoxide, carbon dioxide, and hydrogen into fuel-grade ethanol and derivatives used in fuels, packaging, textiles, and animal feed. LanzaTech operates six commercial plants worldwide and has a broad intellectual property portfolio protecting its technology. The company also holds a significant stake in LanzaJet, a spin-off focused on sustainable aviation fuel production. Its business model combines technology licensing, microbe supply, and co-development investments, enabling recurring revenue streams while partners operate the fermentation plants. LanzaTech’s technology platform is adaptable to diverse feedstocks and is positioned to benefit from global trends in carbon management and renewable fuels [S1].

AirJoule Technologies Corp. focuses on developing and commercializing the AirJoule system, which integrates water generation, industrial dehumidification, and energy-efficient air conditioning technologies. The company is in the early stages of commercialization, having deployed prototype systems for field testing and working towards scaling production and sales. Its business model includes direct sales and Water Purchase Agreements, where customers pay based on water volume rather than system ownership. AirJoule is expanding its operational capabilities, including design, manufacturing, installation, and servicing, to support growth. The company has formed significant partnerships, including a notable deal with Kubota, and unveiled its Prime System to advance commercialization efforts. Despite these developments, AirJoule remains pre-revenue with a history of losses and faces execution and market risks.

First Carolina Financial Services, Inc. is a publicly listed company that completed its initial public offering in June 2026. The company has recently reported quarterly financial results including net income and earnings per share. It has also undergone executive role realignments in mid-2026. Specific details about its sector, industry, and business model are not publicly disclosed in the available data.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in developing therapies targeting galectin proteins, especially galectin-3, which play a role in fibrosis, immune regulation, and cancer. The company’s lead product candidate, belapectin, is a proprietary galectin-3 inhibitor derived from natural plant-based materials. Belapectin is primarily being developed for treatment of metabolic dysfunction-associated steatohepatitis (MASH) with cirrhosis and portal hypertension, as well as certain cancers such as melanoma and head and neck squamous cell carcinoma. The company has conducted multiple clinical trials including Phase 1, Phase 2, and a large Phase 2b/3 NAVIGATE trial evaluating belapectin’s safety and efficacy in preventing esophageal varices in MASH cirrhosis patients. The NAVIGATE trial showed statistically significant reductions in varices incidence in the per-protocol population and U.S. subgroup. Belapectin treatment also improved key fibrosis biomarkers and reduced clinically significant portal hypertension with a safety profile comparable to placebo. Galectin is also pursuing immuno-oncology indications and has a joint venture developing small molecule galectin-3 inhibitors. The company’s financials as of June 30, 2026, show cash and equivalents of $13.27 million but current liabilities of $151.62 million, resulting in a low current ratio of 0.1, indicating liquidity constraints. The company is listed on Nasdaq under ticker GALT.

Strategic Acquisitions Inc is a Nevada-incorporated private lending company focused on providing digital asset-backed loans, primarily collateralized by Bitcoin, to small businesses and individuals outside the United States, mainly in Asia and Europe. The company acquired Exworth Union Inc in December 2022, which operates the lending business. The company’s loan products have fixed terms ranging from 3 to 36 months and loan sizes from $500,000 to $5,000,000. Loans are secured solely by digital assets and include provisions for collateral liquidation upon margin call defaults. The company ceased lending operations in July 2024 after all loans were settled and has not begun developing its proprietary loan servicing platform due to funding constraints. The company faces significant competition from other digital asset lenders, decentralized finance platforms, and traditional financial institutions, many of which operate with fewer regulatory constraints. The company maintains strong liquidity but has a limited operating history, ongoing operating losses, and uncertainty regarding future financing and business model evolution [S1][S2].